Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-19 4:30 pm Purchase |
2022-09-09 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Boxer Capital LLC | 3,421,541 5.700% |
3,421,541 (New Position) |
Filing History |
| 2022-06-15 7:11 pm Unchanged |
2022-06-13 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Capital LLC | 6,323,359 15.100% |
0 (Unchanged) |
Filing History |
| 2022-05-11 5:14 pm Sale |
2022-05-09 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 2,154,058 6.100% |
-988,000 (-31.44%) |
Filing History |
| 2022-03-18 9:00 pm Sale |
2022-03-17 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 3,142,058 8.900% |
-575,201 (-15.47%) |
Filing History |
| 2022-02-14 4:54 pm Sale |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 2,238,861 7.500% |
-238,333 (-9.62%) |
Filing History |
| 2022-02-14 4:47 pm Unchanged |
2021-12-31 | 13G | Atreca, Inc. BCEL |
Boxer Capital LLC | 2,202,333 7.200% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:43 pm Sale |
2021-12-31 | 13G | Matinas BioPharma Holdings, Inc. MTNB |
Boxer Capital LLC | 0 0.000% |
-229,573 (Position Closed) |
Filing History |
| 2022-02-14 4:40 pm Sale |
2021-12-31 | 13G | Solid Biosciences Inc. SLDB |
Boxer Capital LLC | 355,735 4.700% |
-57,615 (-13.94%) |
Filing History |
| 2022-02-14 4:40 pm Sale |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Boxer Capital LLC | 4,082,576 3.600% |
-6,226,674 (-60.40%) |
Filing History |
| 2022-02-14 4:40 pm Sale |
2021-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Boxer Capital LLC | 540,000 1.900% |
-1,063,361 (-66.32%) |
Filing History |
| 2022-02-14 4:36 pm Sale |
2021-12-31 | 13G | DBV Technologies S.A. DBVT |
Boxer Capital LLC | 53,365 1.900% |
-135,000 (-71.67%) |
Filing History |
| 2022-02-14 4:33 pm Sale |
2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
Boxer Capital LLC | 0 0.000% |
-1,675,377 (Position Closed) |
Filing History |
| 2022-02-14 4:28 pm Sale |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Boxer Capital LLC | 0 0.000% |
-1,200,000 (Position Closed) |
Filing History |
| 2022-02-14 4:22 pm Sale |
2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
Boxer Capital LLC | 0 0.000% |
-4,000,000 (Position Closed) |
Filing History |
| 2022-02-14 4:21 pm Sale |
2021-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Boxer Capital LLC | 872,780 3.800% |
-468,750 (-34.94%) |
Filing History |
| 2022-02-14 4:19 pm Sale |
2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Boxer Capital LLC | 0 0.000% |
-1,501,428 (Position Closed) |
Filing History |
| 2022-02-14 4:17 pm Purchase |
2021-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
Boxer Capital LLC | 2,500,000 2.800% |
1,000,000 (+66.67%) |
Filing History |
| 2022-02-14 4:16 pm Purchase |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 2,838,236 6.300% |
570,000 (+25.13%) |
Filing History |
| 2022-02-14 4:14 pm Sale |
2021-12-31 | 13G | Talis Biomedical Corporation TLIS |
Boxer Capital LLC | 0 0.000% |
-103,400 (Position Closed) |
Filing History |
| 2022-02-14 4:10 pm Sale |
2021-12-31 | 13G | Biomea Fusion, Inc. BMEA |
Boxer Capital LLC | 1,188,405 4.100% |
-900,000 (-43.10%) |
Filing History |